Trial NCT00470548

View at ClinicalTrials.gov 
Org. Study IDs: UCDCC#185
Secondary IDs: 224355 ABX027 H3E-US-I017

Last trial update was posted on 2018-01-10

MeSH Interventions

Albumin-Bound Paclitaxel Paclitaxel Pemetrexed

MeSH Conditions

Breast Neoplasms Lung Neoplasms

Other Conditions

Breast Cancer Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Stopping Reasons

Practice patterns with pemetrexed have evolved.

Limitations And Caveats

The phase II portion accrued 37 patients before early closure due to increasing the first-line pemetrexed/platinum doublet use in non-squamous NSCLC.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID